Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8945)
All Articles published online
|
Publishing Process of This Article
|
Feb 21, 2013 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Feng F, Lu YY, Zhang F, Gao XD, Zhang CF, Meredith A, Xu ZX, Yang YT, Chang XJ, Wang H, Qu JH, Zeng Z, Yang JL, Wang CP, Zhu YF, Cui JJ, Yang YP. Long interspersed nuclear element ORF-1 protein promotes proliferation and resistance to chemotherapy in hepatocellular carcinoma. World J Gastroenterol 2013; 19(7): 1068-1078 [PMID: 23466962 DOI: 10.3748/wjg.v19.i7.1068] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i7/1068.htm |
| Number | Citing Articles |
| 1 |
Ananda Ayyappan Jaguva Vasudevan, Ulrike Kreimer, Wolfgang A. Schulz, Aikaterini Krikoni, Gerald G. Schumann, Dieter Häussinger, Carsten Münk, Wolfgang Goering. APOBEC3B Activity Is Prevalent in Urothelial Carcinoma Cells and Only Slightly Affected by LINE-1 Expression. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.02088
|
| 2 |
Baojun Duan, Chen Huang, Jun Bai, Yu Lian Zhang, Xi Wang, Juan Yang, Jun Li. Hepatocellular Carcinoma. 2019; : 141 doi: 10.15586/hepatocellularcarcinoma.2019.ch8
|
| 3 |
Chunzhan Wang, Shengguang Ding, Baisheng Sun, Liang Shen, Ling xiao, Zhihai Han, Haitao Huang. Hsa-miR-4271 downregulates the expression of constitutive androstane receptor and enhances in vivo the sensitivity of non-small cell lung cancer to gefitinib. Pharmacological Research 2020; 161: 105110 doi: 10.1016/j.phrs.2020.105110
|
| 4 |
Raheleh Rahbari, Laleh Habibi, Jose L. Garcia-Puche, Richard M. Badge, Jose Garcia-Perez. Epigenetics Territory and Cancer. 2015; : 51 doi: 10.1007/978-94-017-9639-2_3
|
| 5 |
Peng Cao, Fan Feng, Guofu Dong, Chunyong Yu, Sizhe Feng, Erlin Song, Guobing Shi, Yong Liang, Guobiao Liang. Estrogen receptor α enhances the transcriptional activity of ETS-1 and promotes the proliferation, migration and invasion of neuroblastoma cell in a ligand dependent manner. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1495-3
|
| 6 |
Zi-Yu Wang, Li-Ping Ge, Yang Ouyang, Xi Jin, Yi-Zhou Jiang. Targeting transposable elements in cancer: developments and opportunities. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024; 1879(5): 189143 doi: 10.1016/j.bbcan.2024.189143
|
| 7 |
Qian Yang, Fan Feng, Fan Zhang, Chunping Wang, Yinying Lu, Xudong Gao, Yunfeng Zhu, Yongping Yang. LINE-1 ORF-1p functions as a novel HGF/ETS-1 signaling pathway co-activator and promotes the growth of MDA-MB-231 cell. Cellular Signalling 2013; 25(12): 2652 doi: 10.1016/j.cellsig.2013.08.029
|
| 8 |
Yongsheng Zhang, Lu Han, Jian Pang, Yang Wang, Fan Feng, Qiyu Jiang. Expression of microRNA-452 via adenoviral vector inhibits non-small cell lung cancer cells proliferation and metastasis. Tumor Biology 2016; 37(6): 8259 doi: 10.1007/s13277-015-4725-z
|
| 9 |
Yanni Kou, Shujie Wang, Yanjie Ma, Ning Zhang, Zixiong Zhang, Qian Liu, Yang Mao, Rui Zhou, Dongrong Yi, Ling Ma, Yongxin Zhang, Quanjie Li, Jing Wang, Jinhui Wang, Xile Zhou, Chunnian He, Jiwei Ding, Shan Cen, Xiaoyu Li. A High Throughput Cell-Based Screen Assay for LINE-1 ORF1p Expression Inhibitors Using the In-Cell Western Technique. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.881938
|
| 10 |
Ying-Qi Feng, Bo-An Li, Fan Feng, Yong-Shou Chen, Yi-Xin Ren, Heng Zhang, Shuang Cao. <p>Novel mTOR Inhibitor Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular Targeting Agents</p>. OncoTargets and Therapy 2020; : 7165 doi: 10.2147/OTT.S244474
|
| 11 |
Bin Yang, Chunping Wang, Hui Xie, Yiwu Wang, Jiagan Huang, Yihui Rong, Huixin Zhang, Huifang Kong, Yongping Yang, Yinying Lu. MicroRNA-3163 targets ADAM-17 and enhances the sensitivity of hepatocellular carcinoma cells to molecular targeted agents. Cell Death & Disease 2019; 10(10) doi: 10.1038/s41419-019-2023-1
|
| 12 |
Fan Feng, Qiyu Jiang, Shuang Cao, Yu Cao, Ruisheng Li, Lijun Shen, Hua Zhu, Tao Wang, Lijun Sun, Erguang Liang, Huiwei Sun, Yantao Chai, Xiaojuan Li, Genyan Liu, Ruichang Yang, Zhi Yang, Yongping Yang, Shaojie Xin, Bo-an Li. Pregnane X receptor mediates sorafenib resistance in advanced hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - General Subjects 2018; 1862(4): 1017 doi: 10.1016/j.bbagen.2018.01.011
|
| 13 |
Iman Imtiyaz Ahmed Juvale, Azzmer Azzar Abdul Hamid, Khairul Bariyyah Abd Halim, Ahmad Tarmizi Che Has. P-glycoprotein: new insights into structure, physiological function, regulation and alterations in disease. Heliyon 2022; 8(6): e09777 doi: 10.1016/j.heliyon.2022.e09777
|
| 14 |
Bassier Zadran, Praveen Dhondurao Sudhindar, Daniel Wainwright, Yvonne Bury, Saimir Luli, Rachel Howarth, Misti Vanette McCain, Robyn Watson, Hannah Huet, Fanni Palinkas, Rolando Berlinguer-Palmini, John Casement, Derek A. Mann, Fiona Oakley, John Lunec, Helen Reeves, Geoffrey J. Faulkner, Ruchi Shukla. Impact of retrotransposon protein L1 ORF1p expression on oncogenic pathways in hepatocellular carcinoma: the role of cytoplasmic PIN1 upregulation. British Journal of Cancer 2023; 128(7): 1236 doi: 10.1038/s41416-023-02154-9
|
| 15 |
Jarmila Nahálková. On the interface of aging, cancer, and neurodegeneration with SIRT6 and L1 retrotransposon protein interaction network. Ageing Research Reviews 2024; 101: 102496 doi: 10.1016/j.arr.2024.102496
|
| 16 |
Xiao Shi, Xinxin Si, Ershao Zhang, Ruochen Zang, Nan Yang, He Cheng, Zhihong Zhang, Beijing Pan, Yujie Sun. Paclitaxel-induced stress granules increase <i>LINE-1</i> mRNA stability to promote drug resistance in breast cancer cells. The Journal of Biomedical Research 2021; 35(6): 411 doi: 10.7555/JBR.35.20210105
|
| 17 |
Hui Jia, Qian Yang, Tao Wang, Yu Cao, Qi-yu Jiang, Hong-da Ma, Hui-wei Sun, Ming-xiao Hou, Yong-ping Yang, Fan Feng. Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents. Biochimica et Biophysica Acta (BBA) - General Subjects 2016; 1860(7): 1417 doi: 10.1016/j.bbagen.2016.04.007
|
| 18 |
Liang Cui, Mingyang Li, Fan Feng, Yutao Yang, Xingyi Hang, Jiajun Cui, Jiangping Gao. MEIS1 functions as a potential AR negative regulator. Experimental Cell Research 2014; 328(1): 58 doi: 10.1016/j.yexcr.2014.08.023
|
| 19 |
Heena B Choudhary, Satish K Mandlik, Deepa S Mandlik. Role of p53 suppression in the pathogenesis of hepatocellular carcinoma. World Journal of Gastrointestinal Pathophysiology 2023; 14(3): 46-70 doi: 10.4291/wjgp.v14.i3.46
|
| 20 |
Chengzhan Zhu, Tohru Utsunomiya, Tetsuya Ikemoto, Shinichiro Yamada, Yuji Morine, Satoru Imura, Yusuke Arakawa, Chie Takasu, Daichi Ishikawa, Issei Imoto, Mitsuo Shimada. Hypomethylation of Long Interspersed Nuclear Element-1 (LINE-1) is Associated with Poor Prognosis via Activation of c-MET in Hepatocellular Carcinoma. Annals of Surgical Oncology 2014; 21(S4): 729 doi: 10.1245/s10434-014-3874-4
|
| 21 |
Jiuda Zhao, Zhenzhong Bai, Fan Feng, Erlin Song, Feng Du, Junhui Zhao, Guoshuang Shen, Faxiang Ji, Guoyuan Li, Xinfu Ma, Xingyi Hang, Binghe Xu. Cross-talk between EPAS-1/HIF-2α and PXR signaling pathway regulates multi-drug resistance of stomach cancer cell. The International Journal of Biochemistry & Cell Biology 2016; 72: 73 doi: 10.1016/j.biocel.2016.01.006
|
| 22 |
Afsaneh Lavasanifar, Cierra N. Sharp, Erik A. Korte, Tyler Yin, Keivan Hosseinnejad, Saeed A. Jortani. Long interspersed nuclear element-1 mobilization as a target in cancer diagnostics, prognostics and therapeutics. Clinica Chimica Acta 2019; 493: 52 doi: 10.1016/j.cca.2019.02.015
|
| 23 |
M. Khalid, P. Bojang, A.A.I. Hassanin, E.C. Bowers, E.M. Reyes-Reyes, I.N. Ramos, K.S. Ramos. Line-1: Implications in the etiology of cancer, clinical applications, and pharmacologic targets. Mutation Research/Reviews in Mutation Research 2018; 778: 51 doi: 10.1016/j.mrrev.2018.09.003
|